Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; R factor = 0.049; wR factor = 0.155; data-to-parameter ratio = 24.4.
The title compound, C 14 H 13 NO 3 S, (I), is a second monoclinic polymorph. The original polymorph, (II), was reported by Mahía et al. [Acta Cryst. (1999) , C55, 2158-2160] . Polymorph (II) crystalllized in the space group P2 1 /c (Z = 4), whereas the title polymorph (I) occurs in the space group P2 1 /n (Z = 4). The dihedral angle between the two aromatic rings is 75.9 (1) in (I) compared to 81.9 (1) for (II). In both polymorphs, two S(6) rings are generated by intramolecular N-HÁ Á ÁO and C-HÁ Á ÁO hydrogen bonds, resulting in similar molecular geometries. However, the two polymorphs differ concerning their crystal packing. In (I), molecules are linked into C(8) zigzag chains along the b axis by C-HÁ Á ÁO hydrogen bonds, whereas in (II) molecules are linked by C-HÁ Á ÁO hydrogen bonds, forming C(7) chains along the b axis. The title polymorph is further stabilized by intermolecular C-HÁ Á Á and -interactions [centroid-centroid distance = 3.814 (1) Å ]. These interactions are not evident in polymorph (II).
Related literature
For biological applications of sulfonamides, see: Connor (1998) ; Berredjem et al. (2000) ; Lee & Lee (2002) ; Xiao & Timberlake (2000) . For the first monoclinic polymorph, see: Mahía et al. (1999) . For a related structure, see : Zhang et al. (2010) . For hydrogen-bond motifs, see: Bernstein et al. (1995) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ).
Cg1 is the centroid of the C8-C13 benzene ring. Symmetry codes: (i) x; y þ 1; z; (ii) Àx þ 1; Ày þ 1; Àz.
Data collection: APEX2 (Bruker, 2004 ); cell refinement: APEX2 and SAINT (Bruker, 2004) ; data reduction: SAINT and XPREP (Bruker, 2004 ); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 (Farrugia, 1997) ; software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009 Sulfonamides are an important category of pharmaceutical compounds with a broad spectrum of biological activities such as herbicidal, anti-malarial, anti-convulsant and anti-hypertensive (Connor, 1998; Xiao & Timberlake, 2000; Berredjem et al., 2000; Lee & Lee, 2002) . In this work we report the crystal structure of the title compound (Fig 1, Alternative name: 2-tosylaminobenzaldehyde), which is the second monoclinic polymorph reported.
The original polymorph (compound (II)) was previously reported by Mahía et al. (1999) and was shown to crystallize in the monoclinic space group P2 1 /c, with a = 13.899 (7) (Zhang et al., 2010) .
In both polymorphs, the molecular packing is stabilized by intramolecular N1-H1···O1 and C2-H2···O2 hydrogen bonds, generating two S(6) rings (Bernstein et al., 1995) (Table 1) . However, the two polymorphs differ concerning their crystal packing. In compound (II) molecules are linked to form C(7) chains along the b axis by intermolecular C3-H3···O3 hydrogen bonds whereas in the title compound (I), molecules are linked by intermolecular C14-H14C···O3 hydrogen bonds to form C(8) zigzag chains along the b axis (Fig. 2) . The crystal packing (Fig. 3) is further stabilized by C-H···π interactions between a formylphenyl H atom and the benzene ring (C8-C13) of a neighbouring molecule, with a C5-H5···Cg1 ii distance of 3.658 (2) Å (Table 1 ; Cg1 is the centroid of the C8-C13 benzene ring, Symmetry code: ii = 1 -x, 1 -y, -z). Additional stability arises from aromatic π-π interaction between the benzene rings of neighbouring molecules, with Cg2-Cg2 ii distance of 3.814 (1) Å ( Fig. 3 ; Cg2 is the centroid of the C1-C6 benzene ring, Symmetry code: ii = 1 -x, 1 -y, -z). The C-H···π and π-π interactions are not evident in compound (II).
To a stirred solution of (2-aminophenyl)methanol in chloroform, 1.5 equiv of pyridine and 1.5 equiv of 4-methylbenzene-1-sulfonyl chloride were added at room temperature over a period of 18 h. The resulting brown colored solution was quenched with aqueous HCl. After workup a pale brownish solid was obtained. The combined organic fractions were dried over Na 2 SO 4 and partially concentrated under reduced pressure at 25°C. The product was precipitated with diethylether. Further, MnO 2 was added to a solution of 2-tosylaminobenzyl alcohol in dry 1,2-dichloroethane solvent under nitrogen atmosphere. The suspension was stirred at 80°C in reflux condition for 5 h and filtered through Celite. The filtrate was partially concentrated on a rotatory evaporator at 25°C and the product was precipitated with diethylether.
Recystallization of the product from CH 2 Cl 2 yielded pale yellow crystals of the title compound (Yield: 86%). Crystals of the original polymorph were prepared by evaporation of CHCl 3 from a solution of the title compound at room temperature (Mahía et al., 1999) . with U iso (H) =1.5U eq for methyl H atoms and 1.2U eq (C) for other H atoms.
Computing details
Data collection: APEX2 (Bruker, 2004 ); cell refinement: APEX2 and SAINT (Bruker, 2004) ; data reduction: SAINT and XPREP (Bruker, 2004 ); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 (Farrugia, 1997) ; software used to prepare material for publication: SHELXL97 (Sheldrick, 2008) and PLATON (Spek, 2009 ).
Figure 1
Molecular structure of the title compound with displacement ellipsoids drawn at the 30% probability level. H atoms are presented as a small spheres of arbitrary radius. 
N-(2-Formylphenyl)-p-toluenesulfonamide
Crystal data ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (

